Product ID |
Product Name |
CAS# |
Purity |
Y1106141 |
ethyl 5-(((tert-butoxycarbonyl)amino)methyl)isoxazole-3-carboxylate |
253196-37-1 |
95% |
Y1106142 |
ethyl 4-oxo-4-phenylbutanoate |
6270-17-3 |
95% |
Y1106149 |
2-(2-ethylpiperidin-1-yl)-2-oxoacetate |
53074-96-7 |
95% |
Y1106151 |
3-(chloromethyl)-2-fluoropyridine |
315180-14-4 |
95% |
Y1106152 |
1-(hydroxymethyl)cyclobutane-1-carbonitrile |
956531-83-2 |
95% |
Y1106159 |
7-(diethylamino)-2-oxo-2H-chromene-3-carbaldehyde |
57597-64-5 |
95% |
Y1106160 |
(3-methylquinolin-2-yl)methanamine |
1027763-54-7 |
95% |
Y1106161 |
(2R,3R,4S,5R)-2-((benzoyloxy)methyl)-6-(2,2,2-trichloro-1-iminoethoxy)tetrahydro-2H-pyran-3,4,5-triyl tribenzoate |
151767-11-2 |
95% |
Y1106167 |
2-(aminomethyl)-4-(trifluoromethyl)aniline |
765297-88-9 |
95% |
Y1106169 |
methyl 6-formyl-4-iodopyridine-2-carboxylate |
1393558-18-3 |
95% |
Y1106170 |
tris(2-ethylhexyl)phosphine oxide |
2785-32-2 |
95% |
Y1106176 |
2-oxo-2-(2-(tritylamino)thiazol-4-yl)acetic acid |
68363-44-0 |
95% |
Y1106177 |
6-amino-2-fluoronicotinonitrile |
1445962-29-7 |
95% |
Y1106178 |
4-chloro-2-methoxypyridin-3-ol |
1261685-75-9 |
95% |
Y1106185 |
bradykinin |
58-82-2 |
98% |
Y1106186 |
[SER140]-PLP(139-151) |
122018-58-0 |
98% |
Y1106187 |
Gemigliptin |
911637-19-9 |
98% |
Y1106188 |
5-BDBD |
768404-03-1 |
98% |
Y1106193 |
JNJ-67856633 |
2230273-76-2 |
98% |
Y1106194 |
Sulfopin |
2451481-08-4 |
98% |
Y1106204 |
MRT67307 hydrochloride |
1190379-70-4 |
98% |
Y1106206 |
TLR4-IN-C34 |
40592-88-9 |
98% |
Y1106212 |
BIbo 3304 trifluoroacetate |
191868-14-1 |
98% |
Y1106213 |
NRD167 |
2166487-23-4 |
98% |
Y1106214 |
DAMGO |
78123-71-4 |
98% |
Y1106215 |
Apraglutide |
1295353-98-8 |
98% |
Y1106220 |
Apostatin-1 |
2559703-06-7 |
98% |
Y1106221 |
Conoidin A |
18080-67-6 |
98% |
Y1106223 |
ARP 100 |
704888-90-4 |
98% |
Y1106224 |
Olesoxime |
22033-87-0 |
98% |
Y1106230 |
Rimiducid |
195514-63-7 |
98% |
Y1106232 |
dipivefrin hydrochloride |
64019-93-8 |
98% |
Y1106233 |
Ophiopogonin D |
945619-74-9 |
98% |
Y1106239 |
CC-90009 |
1860875-51-9 |
98% |
Y1106240 |
SBP-7455 |
1884222-74-5 |
98% |
Y1106241 |
FSLLRY-NH2 TFA |
245329-02-6 |
98% |
Y1106242 |
Enfuvirtide acetate |
159519-65-0 |
98% |
Y1106247 |
KY19382 |
2226664-93-1 |
98% |
Y1106248 |
JFD01307SC |
51070-56-5 |
98% |
Y1106249 |
L-NMMA acetate |
53308-83-1 |
98% |
Y1106250 |
Nor-NOHA dihydrochloride |
1140844-63-8 |
98% |
Y1106256 |
CID44216842 |
1222513-26-9 |
98% |
Y1106257 |
CK-869 |
388592-44-7 |
98% |
Y1106258 |
Visomitin |
934826-68-3 |
98% |
Y1106264 |
MYLS22 |
306959-01-3 |
98% |
Y1106265 |
HBX 19818 |
1426944-49-1 |
98% |
Y1106266 |
Lch-7749944 |
796888-12-5 |
98% |
Y1106267 |
TCN201 |
852918-02-6 |
98% |
Y1106272 |
BMS-986158 |
1800340-40-2 |
98% |
Y1106273 |
LY3405105 |
2326428-25-3 |
98% |
Y1106280 |
MK2 Inhibitor III |
724711-21-1 |
98% |
Y1106281 |
TCPOboP |
76150-91-9 |
98% |
Y1106283 |
Sephin-1 |
951441-04-6 |
98% |
Y1106285 |
dihydroresveratrol |
58436-28-5 |
98% |
Y1106290 |
ER-000444793 |
792957-74-5 |
98% |
Y1106291 |
ML359 |
1069858-99-6 |
98% |
Y1106292 |
OUN20985 |
2244520-98-5 |
98% |
Y1106298 |
Parsaclisib hydrochloride |
1995889-48-9 |
98% |
Y1106299 |
JH-X-119-01 |
2227368-54-7 |
98% |
Y1106300 |
STM2457 |
2499663-01-1 |
98% |
Y1106301 |
TPX-0022 |
2271119-26-5 |
98% |
Y1106310 |
boS172722 |
1578245-44-9 |
98% |
Y1106311 |
2-bromo-3,4-dihydro-6-hydroxynaphthalen-1(2H)-one |
1093227-38-3 |
95% |
Y1106312 |
(S)-6,7-dimethoxy-1-(4-(trifluoromethyl)phenethyl)-1,2,3,4-tetrahydroisoquinoline |
769172-81-8 |
95% |
Y1106317 |
2-bromo-N-ethyl-5-methoxyaniline |
914103-95-0 |
95% |
Y1106325 |
N1,N1,2-trimethylpropane-1,2-diamine dihydrochloride |
75975-36-9 |
95% |
Y1106326 |
cyclobutylpiperazine dihydrochloride |
799557-65-6 |
95% |
Y1106327 |
tert-butyl 2-aminoadamantane-2-carboxylate |
502937-07-7 |
95% |
Y1106336 |
7-azido-4-methyl-2H-chromen-2-one |
|
95% |
Y1106337 |
3-methoxy-1,2,4-thiadiazol-5-amine |
98022-43-6 |
95% |
Y1106344 |
Almorexant hydrochloride |
913358-93-7 |
98% |
Y1106345 |
SL327 |
305350-87-2 |
98% |
Y1106346 |
Elacestrant dihydrochloride |
1349723-93-8 |
98% |
Y1106351 |
MGH-CP1 |
896657-58-2 |
98% |
Y1106352 |
LMP744 |
308246-52-8 |
98% |
Y1106353 |
TAS-115 mesylate |
1688673-09-7 |
98% |
Y1106354 |
TAK-659 hydrochloride |
1952251-28-3 |
98% |
Y1106355 |
Indotecan |
915303-09-2 |
98% |
Y1106361 |
(R)-2-(but-3-en-1-yl)oxirane |
137688-20-1 |
95% |
Y1106362 |
(4-methoxyphenyl)(2-methyl-1H-indol-3-yl)methanone |
26211-90-5 |
95% |
Y1106364 |
4-bromo-1-cyclopropylpyridin-2(1H)-one |
1193334-86-9 |
95% |
Y1106371 |
ethyl 3-(tert-butyl)-1,2,4-oxadiazole-5-carboxylate |
163719-73-1 |
95% |
Y1106372 |
pyranoridine phosphate |
76748-86-2 |
95% |
Y1106378 |
6-(N,N,N-trimethylammonio)hexyl bromide |
191086-27-8 |
95% |
Y1106379 |
1-(1H-pyrrol-2-yl)propan-1-one |
1073-26-3 |
95% |
Y1106380 |
(2S,3S)-3-hydroxypyrrolidin-1-ium-2-carboxylate |
4298-08-2 |
95% |
Y1106387 |
methyl 3-chloro-2,2-dimethyl-3-oxopropanoate |
64507-20-6 |
95% |
Y1106394 |
methyl 5-(methylamino)thiophene-2-carboxylate |
859855-63-3 |
95% |
Y1106397 |
2,3,5,6-tetramethoxybenzaldehyde |
34602-86-3 |
95% |
Y1106402 |
4-(bromomethyl)-3-(trifluoromethyl)benzoic acid |
859213-39-1 |
95% |
Y1106403 |
methyl 2-phenyl-1H-imidazole-5-carboxylate |
32682-99-8 |
95% |
Y1106405 |
4-methyl-1,3-dioxan-2-one |
17361-58-9 |
95% |
Y1106411 |
(E)-3-([1,1'-biphenyl]-3-yl)acrylic acid |
60521-26-8 |
95% |
Y1106412 |
2-(4-(4-bromobutyl)piperazin-1-yl)pyrimidine |
87789-48-8 |
95% |
Y1106413 |
3,4,5-tris(dodecyloxy)aniline |
151237-05-7 |
95% |
Y1106420 |
VP3.15 dihydrobromide |
1281681-33-1 |
98% |
Y1106421 |
5-(2-Carboxybenzoyl)-2-chlorobenzenesulfonyl chloride |
68592-12-1 |
95% |
Y1106428 |
5-bromo-2-chloro-N-cyclohexylpyrimidin-4-amine |
864655-05-0 |
95% |
Y1106429 |
brassinolide |
72962-43-7 |
98% |
Y1106431 |
5-methoxy-1H-benzo[d]imidazole-2-sulfonic acid |
106135-28-8 |
95% |